VMD
Income statement / Annual
Last year (2023), Viemed Healthcare, Inc.'s total revenue was $183.01 M,
an increase of 31.82% from the previous year.
In 2023, Viemed Healthcare, Inc.'s net income was $10.24 M.
See Viemed Healthcare, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$183.01 M |
$138.83 M |
$117.06 M |
$131.31 M |
$80.26 M |
$65.27 M |
$46.93 M |
$31.36 M |
$34.60 M |
$23.29 M |
Cost of Revenue |
$70.23 M
|
$54.15 M
|
$43.65 M
|
$51.20 M
|
$24.25 M
|
$16.69 M
|
$12.31 M
|
$12.50 M
|
$7.82 M
|
$3.86 M
|
Gross Profit |
$112.78 M
|
$84.68 M
|
$73.41 M
|
$80.11 M
|
$56.01 M
|
$48.58 M
|
$34.62 M
|
$18.86 M
|
$26.78 M
|
$19.43 M
|
Gross Profit Ratio |
0.62
|
0.61
|
0.63
|
0.61
|
0.7
|
0.74
|
0.74
|
0.6
|
0.77
|
0.83
|
Research and Development Expenses |
$2.78 M
|
$2.70 M
|
$2.11 M
|
$1.08 M
|
$848,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
General & Administrative Expenses |
$93.73 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.68 M
|
$20.25 M
|
$13.77 M
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
-$538,000.00
|
-$5.20 M
|
$0.00
|
$0.00
|
$0.00
|
$268,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$93.20 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.95 M
|
$20.25 M
|
$13.77 M
|
$16.74 M
|
$9.56 M
|
Other Expenses |
$2.48 M
|
$23,000.00
|
-$771,000.00
|
-$3.14 M
|
$671,000.00
|
-$71,000.00
|
$402,000.00
|
$332,000.00
|
$0.00
|
$0.00
|
Operating Expenses |
$98.45 M
|
$76.08 M
|
$61.38 M
|
$55.66 M
|
$46.79 M
|
$31.54 M
|
$20.65 M
|
$14.10 M
|
$16.74 M
|
$9.93 M
|
Cost And Expenses |
$168.68 M
|
$130.23 M
|
$105.03 M
|
$106.86 M
|
$71.04 M
|
$48.23 M
|
$32.96 M
|
$26.60 M
|
$24.56 M
|
$13.79 M
|
Interest Income |
$0.00
|
$197,000.00
|
$318,000.00
|
$509,000.00
|
$314,000.00
|
$0.00
|
$0.00
|
$0.00
|
$87,000.00
|
$48,000.00
|
Interest Expense |
$424,000.00
|
$197,000.00
|
$318,000.00
|
$509,000.00
|
$314,000.00
|
$181,000.00
|
$272,000.00
|
$323,000.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$21.86 M
|
$15.63 M
|
$11.31 M
|
$9.58 M
|
$6.40 M
|
$3.78 M
|
$2.54 M
|
$1.42 M
|
$955,088.00
|
$385,000.00
|
EBITDA |
$36.71 M |
$24.03 M |
$21.84 M |
$30.54 M |
$15.62 M |
$13.89 M |
$11.37 M |
$1.81 M |
$11.94 M |
$9.87 M |
EBITDA Ratio |
0.2
|
0.18
|
0.2
|
0.26
|
0.19
|
0.32
|
0.35
|
0.2
|
0.32
|
0.42
|
Operating Income Ratio |
0.08
|
0.06
|
0.1
|
0.2
|
0.11
|
0.26
|
0.19
|
0.01
|
0.29
|
0.41
|
Total Other Income/Expenses Net |
$61,000.00
|
$738,000.00
|
$923,000.00
|
-$418,000.00
|
-$61,000.00
|
-$386,000.00
|
-$633,000.00
|
-$274,000.00
|
-$87,000.00
|
-$34,000.00
|
Income Before Tax |
$14.39 M
|
$8.99 M
|
$12.50 M
|
$26.36 M
|
$8.80 M
|
$10.34 M
|
$8.19 M
|
$109,000.00
|
$9.96 M
|
$9.45 M
|
Income Before Tax Ratio |
0.08
|
0.06
|
0.11
|
0.2
|
0.11
|
0.16
|
0.17
|
0
|
0.29
|
0.41
|
Income Tax Expense |
$4.15 M
|
$2.77 M
|
$3.38 M
|
-$5.17 M
|
$271,000.00
|
$162,000.00
|
$15,000.00
|
-$1.12 M
|
$1.03 M
|
$0.00
|
Net Income |
$10.24 M
|
$6.22 M
|
$9.13 M
|
$31.53 M
|
$8.53 M
|
$10.18 M
|
$8.18 M
|
$1.23 M
|
$8.93 M
|
$9.45 M
|
Net Income Ratio |
0.06
|
0.04
|
0.08
|
0.24
|
0.11
|
0.16
|
0.17
|
0.04
|
0.26
|
0.41
|
EPS |
0.27 |
0.15 |
0.23 |
0.86 |
0.23 |
0.27 |
0.22 |
0.0324 |
0.24 |
1.58 |
EPS Diluted |
0.25 |
0.15 |
0.22 |
0.82 |
0.22 |
0.26 |
0.22 |
0.0324 |
0.24 |
1.58 |
Weighted Average Shares Out |
$38.35 M
|
$38.66 M
|
$39.49 M
|
$38.74 M
|
$37.72 M
|
$37.89 M
|
$37.91 M
|
$37.91 M
|
$37.91 M
|
$6.00 M
|
Weighted Average Shares Out Diluted |
$40.38 M
|
$39.81 M
|
$40.68 M
|
$40.53 M
|
$39.75 M
|
$39.68 M
|
$37.97 M
|
$37.91 M
|
$37.91 M
|
$6.00 M
|
Link |
|
|
|
|
|
|
|
|
|
|